Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 799 results for "leerink swann llc"

Fox Run Management L.L.C. Buys 3,100 Shares of CVS Health Corporation (CVS)
WKRB News

Leerink Swann Downgrades Cerner Corp. (CERN) to Market Perform

Cerner Corp. (NASDAQ:CERN) was downgraded by equities researchers at Leerink Swann from an outperform rating to a market perform rating in a research note issued on Thursday. They presently have a $50.00 target price on the stock, down from their ... American Banking News, 21 hours ago
[x]  

1 images for "leerink swann llc"

American Banking News, 2 months ago
American Banking News

Biogen Inc. (BIIB) Given New $355.00 Price Target at Leerink Swann

Biogen Inc. (NASDAQ:BIIB) Other equities analysts also recently issued research reports about the company. Piper Jaffray Cos. reiterated a neutral rating on shares of Biogen in a research report on Wednesday, August 3rd. BMO Capital Markets lifted ...
 Mideast Time2 days ago Biogen Inc. (BIIB) Cut to Hold at Vetr Inc.  American Banking News2 hours ago Credit Suisse Group AG Reiterates $8.00 Price Target for Newpark Resources Inc. (NR)  WKRB News1 day ago Mizuho Reiterates Hold Rating for Biogen Inc. (BIIB)  Mideast Time2 days ago
[x]  
WKRB News

Ariad Pharmaceuticals (ARIA) Positive Rating Reaffirmed at Leerink Swann

Leerink Swann restated their positive rating on shares of Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) in a research report report published on Tuesday. Other equities research analysts have also recently issued research reports about the stock.
 WKRB News3 days ago Leerink Swann Reiterates Positive Rating for Ariad Pharmaceuticals Inc. (ARIA)  American Banking News4 days ago Ariad Pharmaceuticals Inc. (ARIA) Earns Positive Rating from Leerink Swann  American Banking News4 days ago
WKRB News

Leerink Swann Weighs in on Heron Therapeutics Inc.'s FY2016 Earnings (HRTX)

Heron Therapeutics Inc. (NASDAQ:HRTX) Investment analysts at Leerink Swann issued their FY2016 earnings per share estimates for Heron Therapeutics in a note issued to investors on Tuesday. Leerink Swann analyst J. Gerberry anticipates that the ...
 WKRB News2 weeks ago Heron Therapeutics Inc. to Post FY2019 Earnings of $1.04 Per Share, Leerink Swann Forecasts (HRTX)  American Banking News2 weeks ago Cardiovascular Systems Inc. to Post FY2019 Earnings of $0.25 Per Share, Leerink Swann Forecasts (CSII)  WKRB News2 weeks ago Leerink Swann Comments on Alnylam Pharmaceuticals Inc.'s FY2016 Earnings (ALNY)  Mideast Time2 weeks ago

Morgan Stanley Upgrades Sanofi (SNY) to Overweight

Sanofi (NYSE:SNY) Other research analysts also recently issued reports about the stock. Leerink Swann reaffirmed a buy rating on shares of Sanofi in a research report on Sunday, October 9th. Berenberg Bank raised shares of Sanofi from a hold ...
 Mideast Time2 days ago Sanofi (SNY) Rating Increased to Overweight at Morgan Stanley  American Banking News4 days ago
WKRB News

FY2018 Earnings Forecast for Tenet Healthcare Corp. Issued By Leerink Swann (THC)

Tenet Healthcare Corp. (NYSE:THC) Leerink Swann lowered their FY2018 earnings per share (EPS) estimates for shares of Tenet Healthcare Corp. in a research note issued on Wednesday. Leerink Swann analyst A. Gupte now expects that the brokerage will ...
 Mideast Time1 week ago FY2016 EPS Estimates for Tenet Healthcare Corp. Decreased by Analyst (THC)  American Banking News5 days ago Analysts Set Expectations for Tenet Healthcare Corp.'s FY2018 Earnings (THC)  American Banking News1 week ago
American Banking News

Investors Buy Shares of Biogen Inc. (BIIB) on Weakness After Analyst Downgrade

Investors bought shares of Biogen Inc. (NASDAQ:BIIB) on weakness during trading on Friday after Leerink Swann lowered their price target on the stock to $355.00. $78.55 million flowed into the stock on the tick-up and $57.64 million flowed out of ...
 American Banking News1 week ago Investors Buy Biogen Inc. (BIIB) on Weakness on Analyst Downgrade  WKRB News6 days ago Traders Buy Shares of Biogen Inc. (BIIB) on Weakness Following Analyst Downgrade  Mideast Time1 week ago
American Banking News

Medtronic PLC (MDT) to Post Q3 2017 Earnings of $1.15 Per Share, Leerink Swann Forecasts

Medtronic PLC (NYSE:MDT) Equities research analysts at Leerink Swann lowered their Q3 2017 earnings estimates for shares of Medtronic PLC in a report released on Tuesday. Leerink Swann analyst D. Antalffy now forecasts that the firm will post ...
 American Banking News1 week ago
American Banking News

Leerink Swann Weighs in on Conmed Corp.'s Q1 2017 Earnings (CNMD)

Conmed Corp. (NASDAQ:CNMD) Equities research analysts at Leerink Swann cut their Q1 2017 earnings per share estimates for Conmed Corp. in a research note issued on Tuesday. Leerink Swann analyst R. Newitter now anticipates that the firm will post ...
 Mideast Time1 week ago Leerink Swann Brokers Cut Earnings Estimates for Conmed Corp. (CNMD)  American Banking News1 week ago
Mideast Time

FY2016 Earnings Forecast for Veracyte Inc. (VCYT) Issued By Leerink Swann

Veracyte Inc. (NASDAQ:VCYT) Equities research analysts at Leerink Swann reduced their FY2016 earnings per share estimates for shares of Veracyte in a report issued on Tuesday. Leerink Swann analyst P. Souda now expects that the brokerage will post ...
 Mideast Time1 week ago Leerink Swann Brokers Lower Earnings Estimates for Veracyte Inc. (VCYT)  Zolmax News1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less